The Hanover Insurance Group, Inc.

  • Market Cap: Small Cap
  • Industry: Insurance
  • ISIN: US4108671052
USD
178.46
-1.52 (-0.84%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About The Hanover Insurance Group, Inc. stock-summary
stock-summary
The Hanover Insurance Group, Inc.
Insurance
The Hanover Insurance Group, Inc. is a holding company. The Company is engaged in providing property and casualty insurance products and services. The Company has three segments: Commercial Lines, Personal Lines, and Other. The Commercial Lines coverages include commercial multiple peril, commercial automobile coverage, workers' compensation coverage and other commercial lines. The Company's Personal Lines coverages include personal automobile coverage and homeowner’s coverage. The personal automobile coverage insures individuals against losses incurred from personal bodily injury, bodily injury to third parties, property damage to an insured's vehicle, and property damage to other vehicles and other property. The homeowner’s coverage insures individuals for losses to their residences and personal property. The Other segment consists of Opus Investment Management, Inc. (Opus), which provides investment advisory services to affiliates.
Company Coordinates stock-summary
Company Details
440 LINCOLN ST , WORCESTER MA : 1653
stock-summary
Tel: 1 508 85510001 508 8552063
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 102 Schemes (51.91%)

Foreign Institutions

Held by 128 Foreign Institutions (6.53%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. P. Kevin Condron
Independent Chairman of the Board
Mr. John Roche
President, Chief Executive Officer, Director
Ms. Cynthia Egan
Chairman of the Board
Mr. Theodore Bunting
Director
Mr. Kevin Bradicich
Independent Director
Ms. Jane Carlin
Independent Director
Mr. Daniel Henry
Independent Director
Mr. Martin Hughes
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
157 Million
stock-summary
Industry

Insurance

stock-summary
Market cap

USD 10,782 Million (Small Cap)

stock-summary
P/E

24.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

117.72%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

17.24%

stock-summary
Price to Book

3.35